Unifarma

Unifarma has been active since 1982 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.3m and a net result of €122,718, of which €150,000 non-recurring income. Equity is shrinking by about 3.3% per year across the filed financial years. Its solvency ranks better than 95% of 5,007 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).